Bulimia Nervosa: Diagnosis, Treatment, and Exam Preparation for Counselors

Bulimia Nervosa: A Clinical Overview

Bulimia Nervosa (BN) is an eating disorder characterized by recurrent episodes of binge eating followed by compensatory behaviors to prevent weight gain. Unlike anorexia nervosa, individuals with BN are typically at a normal weight or may be slightly overweight, which can make the disorder less visible and harder to detect. BN affects approximately 1.5% of women and 0.5% of men over their lifetime.

DSM-5-TR Diagnostic Criteria

1. Recurrent episodes of binge eating, characterized by eating an amount of food that is definitely larger than what most individuals would eat in a similar period under similar circumstances, accompanied by a sense of lack of control over eating
2. Recurrent inappropriate compensatory behaviors to prevent weight gain, such as self-induced vomiting, misuse of laxatives, diuretics, or other medications, fasting, or excessive exercise
3. Both the binge eating and compensatory behaviors occur, on average, at least once a week for three months
4. Self-evaluation is unduly influenced by body shape and weight
5. The disturbance does not occur exclusively during episodes of anorexia nervosa

Severity

Severity is based on the frequency of compensatory behaviors: mild (1 to 3 episodes per week), moderate (4 to 7), severe (8 to 13), and extreme (14 or more episodes per week).

The Binge-Purge Cycle

Understanding the binge-purge cycle is essential for effective treatment. Dietary restriction (skipping meals, rigid food rules) leads to physiological and psychological deprivation. This deprivation increases vulnerability to binge episodes, which are often triggered by negative emotions, interpersonal stress, or simply breaking a dietary rule. After bingeing, intense guilt, shame, and fear of weight gain drive compensatory behaviors. The purge temporarily reduces distress but reinforces the cycle by enabling continued restriction. Breaking this cycle at multiple points is a primary treatment target.

Medical Complications

Self-induced vomiting can cause dental erosion, parotid gland enlargement (chipmunk cheeks), esophageal tears (Mallory-Weiss tears), and electrolyte imbalances (particularly hypokalemia, which can cause cardiac arrhythmias). Laxative misuse can lead to chronic constipation and bowel dysfunction. Russell's sign (calluses on the knuckles from self-induced vomiting) is a characteristic physical finding. Metabolic alkalosis from vomiting and metabolic acidosis from laxative misuse are important lab findings.

Evidence-Based Treatment

CBT-Enhanced (CBT-E)

CBT-E is the gold standard treatment for BN in adults. The treatment typically spans 20 sessions over 20 weeks. Key components include establishing regular eating patterns (three meals and two to three planned snacks), self-monitoring of food intake and associated thoughts and feelings, stimulus control strategies, cognitive restructuring targeting overvaluation of shape and weight, and relapse prevention. CBT-E has the strongest evidence base of any BN treatment, with approximately 50% of clients achieving full remission.

Interpersonal Therapy (IPT)

IPT is an alternative evidence-based treatment that focuses on interpersonal difficulties maintaining the eating disorder. While IPT may take longer to produce results than CBT-E, long-term outcomes are comparable.

Pharmacotherapy

Fluoxetine (Prozac) is the only FDA-approved medication for BN, typically prescribed at 60mg daily (higher than the standard antidepressant dose). Medication is most effective when combined with psychotherapy.

Differential Diagnosis

• Anorexia Nervosa, Binge-Eating/Purging Type: Client is at significantly low body weight
• Binge Eating Disorder: Binge episodes occur without regular compensatory behaviors
• Kleine-Levin Syndrome: Overeating occurs in the context of a neurological sleep disorder

Exam Tips

• Binge eating plus compensatory behaviors must occur at least once per week for three months
• Individuals with BN are typically at normal or above-normal weight
• CBT-E is the first-line treatment for bulimia nervosa
• Fluoxetine at 60mg is the only FDA-approved medication
• The diagnosis cannot be made during an episode of anorexia nervosa
• Russell's sign and parotid gland enlargement are physical findings associated with self-induced vomiting